CN Patent

CN117157095A — 重组人类酸性α-葡萄糖苷酶和其用途

Assigned to Amicus Therapeutics Inc · Expires 2023-12-01 · 2y expired

What this patent protects

本文提供治疗庞贝症的方法，其包括施用重组人类酸性α‑葡萄糖苷酶分子的群体或其医药组合物或调配物，以及药理伴侣。

USPTO Abstract

本文提供治疗庞贝症的方法，其包括施用重组人类酸性α‑葡萄糖苷酶分子的群体或其医药组合物或调配物，以及药理伴侣。

Drugs covered by this patent

Patent Metadata

Patent number
CN117157095A
Jurisdiction
CN
Classification
—
Expires
2023-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Amicus Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.